Framework for developing cost-effectiveness analysis threshold: the case of Egypt.

Autor: Fasseeh AN; Faculty of Pharmacy Alexandria University, Alexandria, Egypt.; Syreon Middle East, Alexandria, Egypt., Korra N; Syreon Middle East, Alexandria, Egypt. nada.korra@syreon.eu., Elezbawy B; Syreon Middle East, Alexandria, Egypt., Sedrak AS; Department of Public Health, Cairo University, Cairo, Egypt.; Egyptian Authority for Unified Procurement, Medical Supply and Technology Management, Cairo, Egypt., Gamal M; Egyptian Authority for Unified Procurement, Medical Supply and Technology Management, Cairo, Egypt., Eldessouki R; Department of Community Health, Fayoum University, Fayoum, Egypt., Eldebeiky M; Egyptian Authority for Unified Procurement, Medical Supply and Technology Management, Cairo, Egypt., George M; Universal Health Insurance Authority, Cairo, Egypt., Seyam A; Universal Health Insurance Authority, Cairo, Egypt., Abourawash A; Egyptian Drug Authority, Cairo, Egypt., Khalifa AY; World Health Organization Representative Office, Cairo, Egypt., Shaheen M; Roche, Cairo, Egypt., Abaza S; Syreon Middle East, Alexandria, Egypt., Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary.

Publikováno v: The Journal of the Egyptian Public Health Association [J Egypt Public Health Assoc] 2024 Jun 03; Vol. 99 (1), pp. 12. Date of Electronic Publication: 2024 Jun 03.

Assessment of safe injection awareness and practices among healthcare providers at primary health care facilities.

Autor: Ali L; Department of Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Faiyum, Egypt. laa01@fayoum.edu.eg., Eldessouki R; Department of Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Faiyum, Egypt.

Publikováno v: The Journal of the Egyptian Public Health Association [J Egypt Public Health Assoc] 2023 Jan 05; Vol. 97 (1), pp. 29. Date of Electronic Publication: 2023 Jan 05.

A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.

Autor: Elezbawy B; Syreon Middle East, Alexandria, Egypt. baher.elezbawy@gmail.com., Fasseeh AN; Syreon Middle East, Alexandria, Egypt.; Eötvös Loránd University, Budapest, Hungary., Sedrak A; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt., Eldessouki R; Fayoum University, Fayoum, Egypt., Gamal M; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt., Eldebeiky M; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt., Amer H; Ain Shams University, Cairo, Egypt., Akeel S; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt., Morsy A; Presidential Program for Women's Health, Ministry of Health and Population (MoHP, Cairo, Egypt., Amin A; Egyptian Pharmaceutical Vigilance Center, Egyptian Drug Authority (EDA), Cairo, Egypt., Shafik A; Ain Shams University, Cairo, Egypt., Abaza S; Syreon Middle East, Cairo, Egypt., Kaló Z; Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary.

Publikováno v: Journal of pharmaceutical policy and practice [J Pharm Policy Pract] 2022 Mar 01; Vol. 15 (1), pp. 10. Date of Electronic Publication: 2022 Mar 01.

POSA259 A Multi-Criteria Decision Analysis (MCDA) Tool for Purchasing Off-Patent Oncology Drugs in Egypt

Autor: Elezbawy, B, Fasseeh, AN, Eldessouki, R, Kirollos, MG, Eldebeiky, M, Sedrak, AS, Amer, H, Elnashar, SAA, Morsy, A, Amin, AA, Saad, AS, Abaza, S, Kalo, Z

Publikováno v: In Value in Health January 2022 25(1) Supplement:S170-S170

Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study.

Autor: Alshahawey, Mona¹ (AUTHOR) mona.elshahawy@pharm.asu.edu.eg, Shawki, May A¹ (AUTHOR), Sayed, Sherihan Ahmed² (AUTHOR), Elseasi, Ahmad³ (AUTHOR), ElWakeel, Lamia¹ (AUTHOR)

Publikováno v: Future Journal of Pharmaceutical Sciences. 10/22/2024, Vol. 10 Issue 1, p1-9. 9p.